New CDC study shows says vaccine coverage has dropped among young children

The sharpest declines in the new CDC study were for vaccines against influenza, with a decrease of 7.4%, to 53.5%; rotavirus, ...

Centivax Closes $37 Million Financing to Accelerate Phase 2 Clinical Development of Universal Flu and Advance Follow-On Portfolio to Clinical Readiness

Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets, today announced the closing of a $37 million ...

Preparing for the next pandemic: Scientists discover a new class of influenza antivirals

Researchers from Leiden University, University of York, University of Barcelona/IQTCUB/ICREA and The Francis Crick Institute ...
Infectious Disease Advisor

Influenza Vaccine Linked to Lower Hospitalization Risk During 2025 to 2026 Season

The 2025-2026 flu vaccine reduced influenza-related outpatient visits and hospitalizations despite an antigenically drifted A(H3N2) strain.

First European case of H9N2 bird flu reported in Italy – what you need to know

A first human H9N2 bird flu case in Europe has been detected in Italy. A virologist explains why the current risk is low and what to watch next.
Medscape

Kidney Risks From COVID Outpace Influenza Impact

COVID is linked to higher risks for subsequent acute kidney injury, chronic kidney disease, and end-stage renal disease than ...
The Daily Illini

Avian influenza threatens University poultry farm

Students and researchers take precautions at the Poultry Research Farm to prevent the spread of avian influenza.
Starts at 60

Flu cases surge as vaccine eligibility expands for over 50s

Australians aged over 50 are urged to review their flu vaccination options as cases rise sharply nationwide and eligibility expands for an enhanced vaccine.